These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 485390)

  • 1. [Sulprostone, an uterospecific prostaglandin E2 derivative. Significance for abortion with special reference to various administration forms].
    Schmidt-Gollwitzer M; Schüssler B; Schmidt-Gollwitzer K
    Arch Gynecol; 1979 Jul; 228(1-4):403. PubMed ID: 485390
    [No Abstract]   [Full Text] [Related]  

  • 2. [Sulprostone, a new prostaglandin E2 derivative (author's transl)].
    Schüssler B; Schmidt-Gollwitzer K; Schmidt-Gollwitzer M
    Dtsch Med Wochenschr; 1979 Nov; 104(48):1697-701. PubMed ID: 520164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of abortion with sulprostone, a uteroselective prostaglandin E2 derivative: intramuscular route of application.
    Schmidt-Gollwitzer K; Hoebich D; Hardt W; Schuessler B; Schmidt-Gollwitzer M
    Int J Fertil; 1981; 26(2):86-93. PubMed ID: 6114070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [1st experiences with abortion induction using sulprostone, a prostaglandin E2 derivative].
    Gethmann U; Oberheuser F
    Arch Gynecol; 1979 Jul; 228(1-4):400-1. PubMed ID: 485388
    [No Abstract]   [Full Text] [Related]  

  • 5. [1st clinical experiences with prostaglandin E derivative sulprostone in extraamnial abortion induction].
    Briel RC; Lippert T; Kidess E; Roemer VM
    Arch Gynecol; 1979 Jul; 228(1-4):425. PubMed ID: 485413
    [No Abstract]   [Full Text] [Related]  

  • 6. [Intramural-intrauterine administration of prostaglandin E2 derivative for abortion induction in semi-hospitalized care in the operating room].
    Wiechell H
    Arch Gynecol; 1979 Jul; 228(1-4):409-10. PubMed ID: 485396
    [No Abstract]   [Full Text] [Related]  

  • 7. [Induced abortion with prostaglandin F2alpha and a new prostaglandin E2 derivative].
    Lichtenegger W
    Wien Med Wochenschr; 1977 Sep; 127(17):536-8. PubMed ID: 919566
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of a new synthetic prostaglandin (sulprostone) in various obstetrical conditions].
    Melis GB; Fruzzetti F; Paoletti AM; Strigini F; Baisi F; Gargiulo T; Pallotti A; Solla E; Sesselego G; Fioretti P
    Minerva Ginecol; 1982 Mar; 34(3):183-90. PubMed ID: 7045735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasma hormone concentrations in abortion induction using sulprostone, a prostaglandin E2 derivative].
    Hoppen HO; Gethmann U
    Arch Gynecol; 1979 Jul; 228(1-4):399-400. PubMed ID: 485387
    [No Abstract]   [Full Text] [Related]  

  • 10. [Abortion induction with the PGE2 derivative sulprostone].
    Dennemark N
    Arch Gynecol; 1979 Jul; 228(1-4):425-6. PubMed ID: 485414
    [No Abstract]   [Full Text] [Related]  

  • 11. [A new therapeutic possibility of abortion in 2d trimester using intravenous administration of sulprostone].
    Schmidt-Gollwitzer K; Schüssler B; Schmidt-Gollwitzer M
    Arch Gynecol; 1979 Jul; 228(1-4):402-3. PubMed ID: 485389
    [No Abstract]   [Full Text] [Related]  

  • 12. [Induction of first and second-trimester abortion by the extra-amniotic administration of a prostaglandin E2-derivate (author's transl)].
    Kunz J; Kunz-Padrutt M; Bänninger U; Reich P; Keller PJ
    Geburtshilfe Frauenheilkd; 1979 Sep; 39(9):798-808. PubMed ID: 510909
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of differentiated PGE2, PGF2alpha and prostaglandin-derivative administration for avoidance of complications in abortion induction].
    Cornely M
    Arch Gynecol; 1979 Jul; 228(1-4):413-4. PubMed ID: 485400
    [No Abstract]   [Full Text] [Related]  

  • 14. [Abortion by extraamnial and intravenous administration of a new prostaglandin E2 derivative].
    Kunz J; Bänninger U; Keller PJ
    Arch Gynecol; 1979 Jul; 228(1-4):423-4. PubMed ID: 485412
    [No Abstract]   [Full Text] [Related]  

  • 15. [Plasmatic coagulation and thrombocyte function in abortion induction with prostaglandin E2 derivative sulprostone].
    Schander K; Budde U; Bellmann O
    Arch Gynecol; 1979 Jul; 228(1-4):635-7. PubMed ID: 485528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Termination of normal and pathological pregnancy with Sulprostone.
    Fischer Z; Chwalisz K; Michałkiewicz W
    Acta Chir Hung; 1986; 27(3):151-6. PubMed ID: 3825407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [First results with a new prostaglandin E2-derivate (author's transl)].
    Schmidt-Gollwitzer M; Schmidt-Gollwitzer K; Schüssler B; Koch R; Nevinny-Stickel J
    Geburtshilfe Frauenheilkd; 1977 Dec; 37(12):1030-8. PubMed ID: 604150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Priming of the cervix with prostaglandins in the first and second trimester].
    Brabec W
    Wien Klin Wochenschr; 1982 Oct; 94(20):554-8. PubMed ID: 7168176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trials of intramuscular sulprostone for second trimester abortion.
    Intaraprasert S; Sugkraroek P
    J Med Assoc Thai; 1988 Mar; 71 Suppl 1():58-62. PubMed ID: 3047304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Termination of pregnancy and evacuation of the uterine contents in the second trimester. Use of a prostaglandin E2 analog: sulprostone].
    Barrat J; Cabrol D; Chouraqui A; Crépin G; Dumez Y; Hacker R; Henrion R; Magnin G; Soutoul JH; Sureau C
    J Gynecol Obstet Biol Reprod (Paris); 1987; 16(1):93-9. PubMed ID: 3584870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.